What Does the US Hemp Roundtable Mean by “95% of Products Eliminated”?

The US Hemp Roundtable’s estimate that 95% of hemp-derived cannabinoid products could be eliminated is a forecast about the effect of a major change in federal hemp law—not a count of products already pulled from shelves. The estimate reflects how many products may fail a new, very low limit on total THC per container once the change takes effect.

The key shift is from focusing mainly on delta-9 THC to counting total THC, including THC that can form when THCA is heated. The law also sets a cap of 0.4 milligrams of total THC per container for covered finished products. That combination could sharply affect products that contain intoxicating cannabinoids, including many flower products.

There is an important date distinction, too. December 11 has been cited as a deadline in discussions of hemp-related rulemaking, but it should not be confused with the effective date of the federal statutory change. The date to confirm depends on the specific notice or agency process being discussed. The statute’s effective date is one year after its enactment: November 12, 2026. Anyone relying on a December 11 deadline should check the relevant agency notice and what that deadline actually requires.

The short version

One-sentence takeaway: “95%” is the US Hemp Roundtable’s estimate of the share of today’s hemp-derived cannabinoid products that may not meet a new per-container total-THC cap—not a government finding that 95% of products are unlawful today.

That distinction matters for businesses planning inventory, testing, labeling, and product reformulation. It also matters for consumers: a product’s current label or compliance with an earlier rule does not necessarily tell you whether it will meet the future federal standard.

What the 95% estimate does—and does not—say

The US Hemp Roundtable is a trade association that represents hemp businesses and advocates for the industry. Its 95% figure is an industry estimate of the potential market impact of the statutory change. It is not an independently audited inventory of every product sold in the United States, and it does not mean that 95% of products have already been banned or removed.

The estimate is best understood as a warning about the breadth of the new threshold. Many products are sold in containers with far more than 0.4 milligrams of THC in total. Under the new limit, a product can face a problem even if its delta-9 THC level is low, because the calculation includes THCA and other THC included in the statutory definition.

“Eliminated” also needs careful interpretation. Some products may be reformulated, sold in a different form, or redesigned to fit the applicable rules. Others may be withdrawn because the economics or technical requirements do not work. The 95% estimate is therefore about products potentially unable to remain on the market in their current form—not necessarily every company disappearing from the sector.

The main change: from delta-9 THC to total THC

Why delta-9 THC alone is no longer the whole story

For years, many hemp products were designed and marketed around a delta-9 THC threshold. A product could have a low measured delta-9 THC result while containing substantial THCA. THCA is a precursor that can convert to delta-9 THC when heated, as happens when flower is smoked or vaporized.

The new framework shifts attention toward total THC, including THCA. The practical implication is straightforward: a certificate showing only delta-9 THC may not provide the information needed to assess compliance. Businesses will need to understand what analytes their laboratory measures, how the laboratory calculates total THC, and whether the test method and report match the rule’s requirements.

Total THC is not interchangeable with delta-9 THC. Nor should anyone claim flower is “THC-free” based on a delta-9-only result when THCA or other relevant THC measurements have not been evaluated. Third-party lab testing can help establish what is in a specific batch, but the test must measure the right things and the result must be interpreted against the applicable standard.

The 0.4 mg per-container cap

The new federal definition sets a limit of 0.4 milligrams of total THC per container for covered finished hemp-derived cannabinoid products. A container is not the same thing as a serving. A product could have a small amount in each serving and still exceed the cap when the contents of the entire container are counted.

This is a particularly significant change because many existing products are designed around consumer doses or concentration limits, rather than a near-zero total amount across the whole package. A multi-serving edible, tincture, or topical product may therefore need to be evaluated by its total contents—not simply by the amount per gummy, dropper, or application.

Issue What to understand Why it matters Delta-9 THC versus total THC Total THC includes THCA under the new approach. A delta-9-only result may not show whether a product meets the standard. 0.4 mg per container The cap applies to the covered product container, not just one serving. Multi-serving products can exceed the limit even when each serving is small. 95% estimate An industry forecast by the US Hemp Roundtable, not a government product count. It signals potential scale, but does not determine the status of any individual product. December 11 deadline Check the specific agency notice or process associated with that date. It should not be mistaken for the statute’s November 12, 2026 effective date.

Why flower shipments are at the highest risk

Flower shipments are especially exposed because flower naturally contains cannabinoid levels that can be far above a 0.4 mg total-THC-per-container limit. The risk is not limited to whether a shipment is called “hemp,” or whether its delta-9 THC result falls below an earlier threshold. The relevant questions include the product’s total THC, how the product is packaged, and how the applicable law treats it.

Shipping creates additional practical complications. A business may have to consider the rules in the state where the product is made, the destination state, carrier requirements, and the federal standard. A hemp flower export to usa lab report does not by itself authorize a shipment, and a label does not override a legal limit. Businesses should avoid assuming that regulators, distributors, or retailers will resolve conflicting paperwork after a shipment is in transit.

For growers and sellers, the first step is to map the supply chain: identify which lots are being tested, how samples are collected, which cannabinoid panel is used, and whether the shipping documents correspond to the actual batch. A result from one lot should not be treated as proof about another.

What the market impact could look like

The market impact of total THC rules could reach beyond flower. Edibles, tinctures, beverages, vape products, and other finished goods may be affected if their total THC per container exceeds the cap. Products with no meaningful THC content may be less exposed to this particular threshold, but that does not automatically establish compliance with every other federal or state requirement.

For manufacturers, possible responses include changing formulations, package sizes, or product lines. Those options require more than a marketing adjustment: a smaller package, for example, does not make a product compliant unless the total amount in that container is within the limit. Businesses also need to review labels, product claims, contracts, and procedures for releasing batches.

Retailers may face choices about purchasing, inventory turnover, and what documentation they require from suppliers. Consumers may see fewer products, different formulations, or revised labels. The US Hemp Roundtable’s estimate signals that the shift could be broad, but actual outcomes will depend on the statutory language, agency implementation, court decisions if any, and the details of each product.

What companies should do before the deadline

1. Confirm which deadline applies. If December 11 is relevant to a rulemaking, identify the specific agency notice, the required action, and whether it is a comment deadline, compliance date, or another milestone. Do not treat it as interchangeable with the statutory effective date of November 12, 2026.
2. Inventory products by formulation and package. Record the cannabinoid profile and the total contents of each container, not just the serving-level amount.
3. Review laboratory methods. Ask whether third-party lab testing measures THCA and other THC forms relevant to the rule, and how the lab derives total THC. Confirm that the report is tied to the exact batch being sold or shipped.
4. Improve access to documentation. Batch lab results posted online can help retailers and customers find current information, but online availability is useful only if reports are genuine, legible, current, and matched to the product lot.
5. Assess reformulation and logistics early. Evaluate whether products can be changed lawfully and consistently, and review how suppliers, processors, distributors, and shipping partners will handle the transition.
6. Get qualified legal advice. The rules may interact with state requirements and other federal obligations. A lab result is evidence about composition, not a legal opinion.

What consumers should look for

Consumers can look for a recent, batch-specific certificate of analysis and check whether it reports THCA as well as delta-9 THC and total THC. Some companies, including Joy Organics, have made laboratory information a visible part of their customer-facing materials; still, consumers should verify that a posted report matches the product and batch they have purchased rather than relying on a brand name alone.

Be cautious of absolute claims such as “THC-free” unless the supporting laboratory report and the claim’s meaning are clear. “Not detected” may refer to a particular analyte, test method, or detection limit; it does not automatically mean that every form of THC is absent. Ask what was tested, when it was tested, and whether the report applies to the product in hand.

USDA’s role—and what it does not settle

The USDA (US Department of Agriculture) administers important parts of the federal hemp production framework, including rules concerning licensed hemp cultivation and testing. But USDA oversight of hemp production should not be confused with a blanket approval of every finished consumer product made from hemp. Businesses must identify which agency and which legal requirement governs each part of their operation.

In plain language: a crop’s status under a production program does not, by itself, prove that a finished product meets the new per-container limit or is lawful in every destination market.

The bottom line

The US Hemp Roundtable’s “95%” figure is a forecast of potential disruption, not a final regulator-issued tally. The underlying concern is concrete: a shift from delta-9 THC alone to total THC, including THCA, combined with a 0.4 mg per-container cap, could make many current formulations—including flower shipments—difficult to sell in their existing form.

Businesses should treat the estimate as a prompt to check products and paperwork, not as a substitute for checking the law. Confirm what December 11 refers to in the specific rulemaking, distinguish it from the November 12, 2026 statutory effective date, and build compliance decisions around batch-specific testing and the actual product container.